Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

M. C. Minnema; M. S. van der Veer; T. Aarts; M. Emmelot; T. Mutis; H. M. Lokhorst

doi:10.1038/leu.2008.247

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells

M. C. Minnema^*, M. S. van der Veer, T. Aarts, M. Emmelot, T. Mutis, H. M. Lokhorst

^*Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	605-607
Number of pages	3
Journal	Leukemia
Volume	23
Issue number	3
DOIs	https://doi.org/10.1038/leu.2008.247
Publication status	Published - 1 Jan 2009

Access to Document

10.1038/leu.2008.247

Link to publication in Scopus

Cite this

Minnema, M. C., van der Veer, M. S., Aarts, T., Emmelot, M., Mutis, T., & Lokhorst, H. M. (2009). Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells. Leukemia, 23(3), 605-607. https://doi.org/10.1038/leu.2008.247

@article{0d1f2ddc10db483c9c30fea9c3758c00,

title = "Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells",

author = "Minnema, {M. C.} and {van der Veer}, {M. S.} and T. Aarts and M. Emmelot and T. Mutis and Lokhorst, {H. M.}",

year = "2009",

month = "1",

day = "1",

doi = "10.1038/leu.2008.247",

language = "English",

volume = "23",

pages = "605--607",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "3",

}

Minnema, MC, van der Veer, MS, Aarts, T, Emmelot, M, Mutis, T & Lokhorst, HM 2009, 'Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells', Leukemia, vol. 23, no. 3, pp. 605-607. https://doi.org/10.1038/leu.2008.247

Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4⁺Foxp3⁺ T cells. / Minnema, M. C.; van der Veer, M. S.; Aarts, T.; Emmelot, M.; Mutis, T.; Lokhorst, H. M.

In: Leukemia, Vol. 23, No. 3, 01.01.2009, p. 605-607.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Lenalidomide alone or in combination with dexamethasone is highly effective in patients with relapsed multiple myeloma following allogeneic stem cell transplantation and increases the frequency of CD4+Foxp3+ T cells

AU - Minnema, M. C.

AU - van der Veer, M. S.

AU - Aarts, T.

AU - Emmelot, M.

AU - Mutis, T.

AU - Lokhorst, H. M.

PY - 2009/1/1

Y1 - 2009/1/1

UR - http://www.scopus.com/inward/record.url?scp=62549095932&partnerID=8YFLogxK

U2 - 10.1038/leu.2008.247

DO - 10.1038/leu.2008.247

M3 - Article

C2 - 18784738

AN - SCOPUS:62549095932

VL - 23

SP - 605

EP - 607

JO - Leukemia

JF - Leukemia

SN - 0887-6924

IS - 3

ER -